Gaucher's disease is well established, little is known concerning the pathogenic mechanisms involved in the clinical manifestations of the disease. In order to obtain insight into this unexplored aspect of Gaucher's disease, we examined the effects of glucocerebroside (GL1) at the cellular level in monolayers of cultured murine macrophages. The addition of GL1 to these cultures stimulated the macrophages to release increased amounts of lymphocyte-activating factor (LAF) and lysosomal enzymes into the medium. These responses were proportional to the amount of GL1 added to the culture. At higher levels of GL1 (.20 ,ug/ml), lactic dehydrogenase, a cytoplasmic enzyme was also released indicating cellular damage at these doses.
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Intracellular LAF also increased in macrophages incubated with the high doses of GL1, demonstrating an increase in total LAF production by these cells. Lipopolysaccharide acted synergistically with GL1 and stimulated the release of exceedingly high levels of LAF which had a molecular weight profile similar to that of LAF released by exposure to lipopolysaccharide alone. Unlike GL1, galactocerebroside, sphingomyelin, and ceramidetrihexoside, exerted little or no effect on the release of macrophage products. The effect of GL, was selective for macrophages since addition of this material to mouse lens epithelial cells had no detectable cytotoxic effect and it was only slightly toxic to lymphocytes or P815 cells in concentrations at which macrophages were clearly affected. A direct relationship was observed between the cytotoxicity of the sphingolipids and their accumulation in various cells. Macrophages accumu-
INTRODUCTION
Gaucher's disease, an autosomal recessive lipid storage disorder, is characterized by the deficiency of glucocerebrosidase and the accumulation of its substrate, glucocerebroside (GL1)1 in phagocytic cells ("Gaucher cells") throughout the reticuloendothelial system. The disease is multifaceted and its pathogenesis is not completely understood (1, 2) .
Very little is known about the effects of GL1 on macrophages (MO) in culture and to the best of our knowledge, no study on this topic has been reported previously. The present study was aimed at examining the effects of GL1 on MO cultures. The parameters tested included the release of lysosomal and cytoplasmic enzymes, as well as of a monokine, lymphocyte-activating factor (LAF (3) (4) (5) (6) , also designated Interleukin 1 (7) Enzyme assays. l3-N-Acetylglucosaminidase (hexosaminidase) was determined by the method of Pugh et al. (10) . The assays were carried out in duplicate, with the means differing from the actual values by <15%. Lactate dehydrogenase (LDH) was assayed by the method of Amador et al (11) . The levels of enzymatic activities in the supernates are presented as percent of the total activity in the culture (supemate + cell lysate).
Inhibition of nucleic acid synthesis. This assay was carried out in flat bottomed microplates (6 x 8 mm, Linbro), with the cultures set up in triplicate, in a final volume of 0.2 ml of RPMI 1640 medium with 5% FCS. The cultures consisted of (a) 4 [3H]GL, was prepared from the same unlabeled GL, used in this study and cochromatographed with it on thin layer silica gel G. Labeled ROS were prepared as described (13) and kindly provided by Dr. Paul O'Brien (National Eye Institute). Unlabeled sphingolipids, at 30 .g/ml, were added to the suspensions of the labeled GL1 and SPM. After incubation for various intervals, at 37°C or 4°C, the monolayers were washed thoroughly with PBS and lysed in 0.5 ml NaOH, 0.2 N. The radioactivity was measured by scintillation counting in aliquots of 0.1 ml, treated with 0.5 ml of NCS tissue solubilizer (Amersham Corp., Arlington Heights, Ill) and mixed with 10 ml of Betafluor (National Diagnostics Inc., Advanced Applications Institute Inc., Parsippany, N. J.)
The protein content of the monolayer lysates was determined by the method of Lowry et al. (14) . The results are presented as both the specific uptake, (mean disintegrations per minute per milligram protein) and as the percent of the total added isotope. The levels of specific uptake in the individual dishes differed by <10% from the mean values.
RESULTS
Effects ofGL1 on the release ofLAF and enzymes by M+O. The results obtained in two experiments in which the release of various cell products was measured after incubation of MO monolayers with various concentrations of GL1 are illustrated in Fig. 1 . The addition of GL1 caused an increase in the release of the monokine, LAF, the lysosomal enzyme, hexosaminidase, and the cytoplasmic enzyme, LDH, in a dosedependent fashion. The increase in release of LDH indicatps cell damage (15, 16) . It is noteworthy that the release of LAF and hexosaminidase was particularly elevated at toxic doses of GL1, although an apparent increase in LAF release was observed in cultures with no detectable elevation of LDH release (with GL1 at -20 ,ug/ml or less). A known M4 stimulant, LPS, 2 The term "accumulation" was used in the present study to describe the process in which labeled particles become associated with cell monolayers. This process may include both binding and actual phagocytosis or pinocytosis. moderately increased the release of LAF and hexosaminidase, but had no effect on LDH release. GL1 also increased the release of two other lysosomal enzymes, ,B-galactosidase and glucuronidase (data not shown), but the changes were less consistent than those observed with hexosaminidase. Silica particles, a known cytotoxic agent for MO (17) , were used as control in other experiments to examine the effect ofdamage on the MO product release. The effects of silica resembled those of GL1, namely, at subtoxic concentrations (<25 Aglml), only LAF release was increased, whereas at toxic higher doses, larger amounts of LAF were released, along with an increased release of LDH and hexosaminidase.
Synergy between GL1 and LPS. MO monolayers incubated with combinations of GL1 and LPS released LAF in amounts greatly exceeding those secreted by cultures stimulated by the individual agents (Table I) . It is noteworthy that the release of substantial amounts of LAF in the presence of LPS and GL1 at 10 ,ug/ml was not accompanied by an increase in the release of LDH; the combination of LPS and GL1 at 30 ,ug/ml produced very high levels of LAF, along with elevated LDH release. Hexosaminidase secretion in these experi- (19) . The data of two experiments are shown in Fig. 3 . Lens epithelial cells were found refractory to GL1, whereas spleen and P815 cells were moderately inhibited by high concentrations of this sphingolipid. SPM and CTH affected cells other than Mo similarly to GL, (data with CTH are not shown). All tested cells were highly inhibited by the surface active agent, lysophosphatidyl choline (LPC) and moderately affected by soybean intralipid (SB-IL). Mo accumulated large quantities of GL1 and showed high susceptibility to its effects. (b) SPM was not accumulated by M4 and had minimal or no effect on these cells. The relationship between accumulation and damaging capacity of GL1 was further confirmed in experiments in which untreated ("resident")
Mo were compared to MO activated in vivo by BCG bacteria. The activated Mo accumulated 3-10 times less [3H]GL1 than the resident MO and were refractory to its damaging effects.3
The selectivity of GL1 for Mo in vitro (Table IV) may be related to the exclusive accumulation of this sphingolipid in the reticuloendothelial system of patients with Gaucher's disease (1, 2) . The mechanism that regulates the selective uptake of GL1 by Mo is not known. The possibility that cells other than M4 did not accumulate GL, because of high levels of the specific enzyme, glucocerebrosidase (GL1ase) is not consistent with the finding that the levels of this enzyme were similar in Mof and lens epithelial cells (114.7 and 128.7 U/mg protein, respectively). It is known that glucose moieties have some affinity for the mannose receptor of M4 (26) . The possibility that this or another receptor is involved in binding and uptake of glycolipids is currently under investigation.
The present study thus shows that Mo cultures may be useful for investigating the interactions between GL1 and the reticuloendothelial system. Although the relationship between the phenomena observed in vitro and those occurring in vivo is not clear, it is tempting to speculate that the findings reported here are related to certain clinical features of Gaucher's disease. It is conceivable that an increased release of products by GL,-affected M4 could participate in bringing about damage to liver and bone marrow (21) , increased levels of lysosomal enzymes (23) , or the abnormally high frequency of gammopathies (27) in Gaucher's disease.
